Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer

Research output: Contribution to journal › Journal article › Research › peer-review

  • Christina Annette Bjerre
  • Ann Knoop
  • Karsten Bjerre
  • Mathilde S. Larsen
  • Katrine L. Henriksen
  • Maria Bibi Lyng
  • Henrik Ditzel
  • Birgitte B Rasmussen
  • Nils Brünner
  • Bent Ejlertsen
  • Anne-Vibeke Lænkholm
The role of tissue inhibitor of metalloproteinases-1 (TIMP-1) in estrogen receptor (ER) positive breast cancer remains to be fully elucidated. We evaluated TIMP-1 as a prognostic marker in patients treated with adjuvant tamoxifen and investigated TIMP-1s association with Ki67 and ER/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2) profiles.
Original languageEnglish
JournalActa Oncologica
Volume52
Issue number1
Pages (from-to)82-90
Number of pages9
ISSN0284-186X
DOIs
Publication statusPublished - 2013

    Research areas

  • Aged, Antineoplastic Agents, Hormonal, Breast Neoplasms, Cohort Studies, Female, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Kaplan-Meier Estimate, Ki-67 Antigen, Middle Aged, Multivariate Analysis, Prognosis, Receptor, erbB-2, Receptors, Estrogen, Receptors, Progesterone, Tamoxifen, Tissue Inhibitor of Metalloproteinase-1

ID: 59304932